Kuehne + Nagel and GlaxoSmithKline (GSK) have signed an end-to-end global logistics partnership until 2021 that will see Kuehne + Nagel run the core business of transporting products from the raw materials supplier to trade customers for the leading global healthcare company.
The contract officially marks the commencement of a relationship which brings significant logistics alignment between the two companies; Kuehne + Nagel will provide skills, expertise and strategic capability to deliver enhanced value across GSK’s global supply chain operations.
With numerous suppliers, a large number of manufacturing units and a -variety of specific routes to patients and consumers in over 100 countries, GSK requires a sophisticated and truly global end-to-end logistics solution. Kuehne + Nagel was selected as a partner due to its existing track record with GSK, strength in the industry, maturity of Integrated Logistics provision and significant investment strategy in pharmaceuticals and consumer products logistics.
Detlef Trefzger, Chief Executive Officer of Kuehne + Nagel International AG, stated: “We are very excited about this long term collaboration with GSK. Our focus is to leverage existing experience and industry-specific solutions serving the pharmaceutical and consumer sector which will deliver incremental benefits to GSK. Our integrated logistics approach, comprising air, sea, overland services and Logistics Control Centres in four regional hubs will enable GSK’s global supply chains to move to the next level of performance.”
The new working relationship is a transformational development for both GSK and Kuehne + Nagel in its scale and ambition. It is one of Kuehne + Nagel’s biggest customer awards and marks significant progress towards realising both GSK’s ambition of a world class supply chain and Kuehne + Nagel’s goal to be the leading provider of end-to-end solutions in the pharmaceutical and consumer sectors.